ArticleScientific reports2025
Estimation of micro-extraction process hippuric acid for toluene exposure monitoring in urine samples.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analyses of dextroamphetamine and its metabolites in human urine by capillary electrophoresis with diode array and capacitively coupled contactless conductivity detection (CE-DAD-CAnalytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study employed a quick, efficient, sensitive, and easy-to-use micro-extraction process to monitor biomarker hippuric acid (BIHA) in urine samples as a bioindicator of exposure to toluene with an HPLC-DAD instrument. The independent variables for the micro-extraction process of hippuric acid were examined, while the response from the HA monitoring acted as the dependent variable. Initial screening and parameter optimization were performed using the multivariate models. The desirability function aimed to maximize the extraction recovery of hippuric acid while minimizing solvent volume and extraction time. The best conditions identified were: 152 µL of extractant solvent, extraction time 253 s (4.2 min), a salt amount of 3.9%W/V, and pH = 2.7 with Desirability = 1. Achieving Desirability = 1 reflects a perfect compromise of all goals. The suggested model showed strong validation, evidenced by adjusted R² = 0.9888, high recovery rates, low error in confirmation runs (1.37-2.09%), and consistent predicted values. The model demonstrated satisfactory recovery rates, emphasizing its potential for analyzing urine samples as an indicator of toluene exposure. The detection limit was established at 0.15 ng mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.